KINETISOL Trademark

Trademark Overview

On Wednesday, January 17, 2024, a trademark application was filed for KINETISOL with the United States Patent and Trademark Office. The USPTO has given the KINETISOL trademark a serial number of 98360843. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, May 16, 2025. This trademark is owned by AustinPx, LLC. The KINETISOL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Pharmaceutical research services
kinetisol

General Information

Serial Number98360843
Word MarkKINETISOL
Filing DateWednesday, January 17, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, May 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements

Goods and ServicesPharmaceutical research and development; Pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 17, 2024
Primary Code042
First Use Anywhere DateSunday, November 16, 2008
First Use In Commerce DateSunday, November 16, 2008

Trademark Owner History

Party NameAustinPx, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGeorgetown, TX 78626
Party NameAustinPx, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGeorgetown, TX 78626

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024NEW APPLICATION ENTERED
Monday, January 22, 2024TEAS REQUEST TO MAKE SPECIAL RECEIVED
Wednesday, February 21, 2024ASSIGNED TO EXAMINER
Monday, February 12, 2024ASSIGNED TO PETITION STAFF
Wednesday, February 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 14, 2024REQUEST FOR SPECIAL HANDLING - GRANTED
Friday, May 17, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, May 17, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, February 21, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 21, 2024NON-FINAL ACTION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 26, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 16, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 16, 2025TEAS STATEMENT OF USE RECEIVED
Friday, May 16, 2025SOU EXTENSION 1 FILED
Saturday, May 17, 2025SOU EXTENSION 1 GRANTED
Saturday, May 17, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

kinetisol pharmaceutical research services development